Skip to main content

Academy Leads Coalition Response to CMS’ Unacceptable Medicare Advantage Step Therapy Policies

Our profession continues to spearhead efforts to unfetter access to necessary ophthalmic treatments.  

The Academy orchestrated a unified response by ophthalmology this week in our latest effort to halt federal fail-first policies that will hurt Medicare Advantage’s beneficiaries by delaying necessary care. In comments to the Centers for Medicare & Medicaid Services, an Academy-led coalition, including the American Society of Cataract and Refractive Surgeons, the American Glaucoma Society, the American Society of Retina Specialists and the Retina Society, believe that the agency’s implementation of step therapy is unacceptable. 

Our coalition contends that CMS is failing to do enough to ensure that step therapy will not impede patients’ timely access to Part B drugs. Additionally, a united profession of ophthalmology is again challenging the legality of the policy. It is our longstanding belief that CMS lacks the authority to permit its Medicare Advantage plans to impose such a coverage tool. 

Medicare Advantage plans are now allowed to force step therapy for beneficiaries, a change that took effect at the beginning of the month. CMS is permitting Medicare Advantage plans to require that patients’ treatment start with a drug chosen by the health plan — even an off-label option. 

Our coalition letter to CMS Administrator Seema Verma raises several critical points that justify the immediate halt of step therapy in Medicare. First, the concept of step therapy is antithetical to the requirement that Medicare Advantage plans provide equal access to and coverage of Part B drugs as original Medicare. Second, CMS’ proposals are inadequate to ensure that imposition of step therapy will not interfere with access to Part B drugs. 

The agency says that step therapy allows Medicare Advantage plans the ability to negotiate drug prices, which could lower costs. However, the Academy believes that it inserts substantial obstacles between patients and their physicians’ recommended treatment options.

Related Stories

Member exclusive - Locked
Step therapy has to go

Federal Watchdog to Investigate Step Therapy in Medicare Advantage Plans, at Academy’s Urging

The Academy met with the HHS Office of Inspector to continue pressing our concerns about step therapy. The meeting follows the OIG’s September 15 announcement that it will review how Medicare Advantage plans use prior authorization and step therapy for Part B drugs, a review the Academy urged.  
 

Member exclusive - Locked Fallback image

Advocacy Works: Academy Pushes Humana to Correct 1.8 Million Denied Claims

Responding to members, the Academy fought Humana's mass denials and won. Here's what your practice needs to know to recover affected payments.

Member exclusive - Locked Fallback image

Advocacy Works: Humana Backs Down on Claim Denials

When Humana started denying valid claims for office and eye visits billed with diagnostic testing, the Academy fought back — and won.

Latest Updates

Member exclusive - Locked
capital building side

OPHTHPAC Midterms Recap: What the Results Mean for Ophthalmology

The 2026 midterm results are nearly final, and thanks to the support of ophthalmologists nationwide, OPHTHPAC helped secure important victories for ophthalmology this election cycle: 100 of 114 OPHTHPAC-backed candidates won their general election races, with a few results still being finalized. Here is what this year’s results mean for ophthalmology.

Member exclusive - Locked
capital building side

Final Hospital Outpatient, ASC Rule: Pay Raises for Device-Intensive Procedures, But Cuts to Other Common Ophthalmic Surgeries

Hospital outpatient departments (HOPD) and ambulatory surgical centers will get a 2.3% payment increase in 2027. But the rule released Nov. 4 by the Centers for Medicare & Medicaid Services includes hidden reimbursement cuts for most ophthalmology surgeries.

Member exclusive - Locked
HHS

2027 Fee Schedule Finalizes Pay Cut to Physicians Between 1.8% and 2.3%

The final rule from the Centers for Medicare & Medicaid Services (CMS) includes a 2.31% payment cut for physicians not participating in qualifying APMs and a 1.83% pay cut for qualifying Alternative Payment Model (APM) participants.